Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Phac4g01635 | ATGAAAGGTGTGTTGGCTTTTCTTGGCAAGCTCAGAAAGCACTTTCTGTTGCTTCTTGTGGCAATGGAGCTCCTGCTGCTTCTTCTCTCTCCTTTTGCTTCTCCTCTCAGTGATGAAGGACAAGCATTGATGAAGATTAAGGCTTCATTCAGCAATGTAGCAGATGTTCTGCATGATTGGGATGATTTGCATAATGACGACTTCTGTTCCTGGAGAGGAGTCTTGTGTGACAATGTCAGCCTTACTGTTCTTTCTCTAAACTTGTCAAACTTGAACCTTGGTGGGGAGATACCACCGGCCATTGGTGACTTAGGAAACTTGCAATCCATAGACCTGCAGGGGAATAAATTAACTGGTCAAATTCCAGATGAAATTGGGAATTGTGCTGCACTTATTCATCTGGATTTGTCTGATAATCAGTTATATGGTGATATACCCTTCTCCATATCAAAACTAAAGCAGCTTGTGTTCCTGAATTTAAAGAGTAATCAGTTGACTGGTCCTATCCCTTCAATTTTAACCCAAATTCCTAACTTGAAGACTCTCGATCTTGCACGAAATAGACTCACTGGTGAGATTCCAAGGCTACTCTACTGGAATGAAGTCCTGCAGTACCTCGGGTTGCGAGGGAACATGTTGAGTGGAACTCTGTCGCCTGATATCTGTCAATTAACTGGTTTGTGGTATTTTGATGTGAGAGGCAATAACTTGACTGGCACCATACCTGAGAGCATTGGAAACTGTACAAATTTTGAAATATTGGATCTGTCATATAACCAGATTTCTGGGGAGATTCCCTATAATATTGGATTTCTTCAAGTAGCTACTTTGTCACTTCAAGGAAATAGATTAACTGGTAAGATTCCGGAAGTCATTGGTTTAATGCAAGCCCTTGCCATTTTGGATTTGAGTGAGAATGAGCTGATAGGACCCATCCCTCCCATACTAGGCAATCTGTCTTTTACTGGCAAGCTGTACCTTCATGGAAACATGATAACTGGACCAATACCTCCAGAACTTGGCAATATGTCAAGACTAAGCTACCTGCAATTAAATGACAATCAACTAGTTGGCCAAATTCCCAATGAACTTGGGAAGCTCGAACACTTGTTTGAATTGAATCTTGCCAATAATCATCTTGAAGGATCTATTCCACTTAACATTAGCTCCTGTACGGCCTTGAATAAGTTTAATGTGCATGGAAATCATTTAAATGGTTCAATTCCTTTGAGCTTTAGCAGCCTTGAAAGCTTGACTTACTTAAATCTTTCTGCAAACAACTTCAAAGGGATTATACCTGTTGAGTTAGGCCATATAATAAATCTTGATACGTTGGATCTATCTAGCAATAATTTTTCAGGGCATGTTCCAGGGTCTGTTGGTTATCTTGAGCATCTTCTAACCTTGAACTTAAGCCATAACAGTCTTCAGGGTCCCTTGCCTGCTGAATTTGGAAATCTTAGAAGCATACAAATTATTGACATCTCATTCAACCATCTCTTGGGTAGTATGCCTCCAGAAATTGGCCAGCTGCAGAATCTTGTGTCTCTGATTTTAAACAACAATGATTTGCGTGGGAAGATTCCAGATCAGCTTACAAATTGCTTAAGTCTGAACTTCCTGAATGTCTCATATAATAACTTATCCGGGGTCATTCCTCTAATGAAGAACTTCTCACGGTTTTCAGATGACAGCTTCATTGGAAATCCATTATTATGCGGAAATTGGTTAGGATCCATATGTGATCCTTACATACCAAAATCCAGAGTGGTTTTCTCAAGGGCTGCAGTTGTTTGTCTCATAGTTGGTACCATCATATTACTGGCGATGGTAACGGTTGCTCTCTACAGATCAAGCCAATCCATGCAATTGATTAAAGGATCCAGCGGAACTGAGCAAGGGCCACCCAAGCTTGTAATTCTTCATATGGGCCTGGCCATCCATACTTTTGATGATATTATGAGAGTTACCGAGAATCTCAATGAGAAGTATATTGTAGGATATGGTGCCTCAGGTACCGTGTACAAGTGTGTTTTGAAGAATTCCCGGCCAATTGCAATTAAACGGCTATACAACCAGCATCAACACAACTCAAGGGAGTTTGAGACAGAACTTGAAACTATTGGCAGCATCAGACACAGGAATCTTGTCACCTTGCATGGTTATGCTCTAACTCCTAATGGAAATCTTCTTTTCTATGACTATATGGAGAATGGCTCTCTGTGGGATCTTCTTCATGGTCCCTTGAAAAAGGTTAAACTTGATTGGGAAGCACGCTTGAGGATTGCTGTGGGAGCTTCTGAAGGACTTGCTTACCTCCATCATGACTGCAATCCTAGAATTATTCACAGGGATATTAAGTCCTCAAATATCCTGATAGATGAGAACTTTGAAGCTCGCCTGTCTGATTTTGGCATTGCCAAATGTTTATCAACTACAAGAACTCATGCATCAACGTCTGTGCTTGGGACCATAGGCTATATTGACCCGGAGTATGCCCGGAGTTCTAGGTTGAATGAAAAATCCGACGTGTATAGCTTTGGTATTGTTCTACTTGAGCTACTAACTGGGAAGAAAGCAGTGGACAATGATTCCAACTTGCATCACTTGGTAAGTATTTTCTGCATTTTTTTTCTGATGATTCAGTCTTTAATCAAGCAGAATAGTATATTATCTAAGGCAGATAACAACACTATAATGGAGACTGTGGATCCTGAGGTGTCTATTACCTGCATGGATCTGACCCATGTTAAGAAGACCTTTCAGCTTGCTCTTCTTTGCACAAAAGGAAACCCTTCTGAGAGGCCAACTATGCATCAGGTTGCCAGGGTTTTGGCATCACTACTCCCTGCACCTCCCAGCAACATCTTTGCCCCTCCTTCAAAGACCATTGATTATGCACAAATTGTGATTCAAAAGGGAAACAACCTCCATCCCCCACAATTGGAAAGGTTACAATCTCAGAAGTACTCTAATGATCAATGGTTTGTTCGCTTTGAGAATGTTGTATCAAATAACAGCCTATAG | 3027 | 0.409 | MKGVLAFLGKLRKHFLLLLVAMELLLLLLSPFASPLSDEGQALMKIKASFSNVADVLHDWDDLHNDDFCSWRGVLCDNVSLTVLSLNLSNLNLGGEIPPAIGDLGNLQSIDLQGNKLTGQIPDEIGNCAALIHLDLSDNQLYGDIPFSISKLKQLVFLNLKSNQLTGPIPSILTQIPNLKTLDLARNRLTGEIPRLLYWNEVLQYLGLRGNMLSGTLSPDICQLTGLWYFDVRGNNLTGTIPESIGNCTNFEILDLSYNQISGEIPYNIGFLQVATLSLQGNRLTGKIPEVIGLMQALAILDLSENELIGPIPPILGNLSFTGKLYLHGNMITGPIPPELGNMSRLSYLQLNDNQLVGQIPNELGKLEHLFELNLANNHLEGSIPLNISSCTALNKFNVHGNHLNGSIPLSFSSLESLTYLNLSANNFKGIIPVELGHIINLDTLDLSSNNFSGHVPGSVGYLEHLLTLNLSHNSLQGPLPAEFGNLRSIQIIDISFNHLLGSMPPEIGQLQNLVSLILNNNDLRGKIPDQLTNCLSLNFLNVSYNNLSGVIPLMKNFSRFSDDSFIGNPLLCGNWLGSICDPYIPKSRVVFSRAAVVCLIVGTIILLAMVTVALYRSSQSMQLIKGSSGTEQGPPKLVILHMGLAIHTFDDIMRVTENLNEKYIVGYGASGTVYKCVLKNSRPIAIKRLYNQHQHNSREFETELETIGSIRHRNLVTLHGYALTPNGNLLFYDYMENGSLWDLLHGPLKKVKLDWEARLRIAVGASEGLAYLHHDCNPRIIHRDIKSSNILIDENFEARLSDFGIAKCLSTTRTHASTSVLGTIGYIDPEYARSSRLNEKSDVYSFGIVLLELLTGKKAVDNDSNLHHLVSIFCIFFLMIQSLIKQNSILSKADNNTIMETVDPEVSITCMDLTHVKKTFQLALLCTKGNPSERPTMHQVARVLASLLPAPPSNIFAPPSKTIDYAQIVIQKGNNLHPPQLERLQSQKYSNDQWFVRFENVVSNNSL* | 1009 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Phac4g01635 | 1008 | SMART | serkin_6 | 660 | 949 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac4g01635 | 1008 | Pfam | Leucine rich repeat N-terminal domain | 37 | 77 | IPR013210 | - | |
Phac4g01635 | 1008 | SMART | LRR_typ_2 | 224 | 248 | IPR003591 | - | |
Phac4g01635 | 1008 | SMART | LRR_typ_2 | 367 | 391 | IPR003591 | - | |
Phac4g01635 | 1008 | SMART | LRR_typ_2 | 415 | 438 | IPR003591 | - | |
Phac4g01635 | 1008 | SMART | LRR_typ_2 | 176 | 200 | IPR003591 | - | |
Phac4g01635 | 1008 | SMART | LRR_typ_2 | 104 | 128 | IPR003591 | - | |
Phac4g01635 | 1008 | SMART | LRR_typ_2 | 463 | 486 | IPR003591 | - | |
Phac4g01635 | 1008 | SMART | LRR_typ_2 | 511 | 535 | IPR003591 | - | |
Phac4g01635 | 1008 | Pfam | Leucine Rich repeat | 247 | 264 | IPR001611 | GO:0005515 | |
Phac4g01635 | 1008 | Pfam | Leucine Rich repeat | 177 | 192 | IPR001611 | GO:0005515 | |
Phac4g01635 | 1008 | Pfam | Leucine rich repeat | 441 | 500 | IPR001611 | GO:0005515 | |
Phac4g01635 | 1008 | Pfam | Leucine rich repeat | 106 | 165 | IPR001611 | GO:0005515 | |
Phac4g01635 | 1008 | Gene3D | Ribonuclease Inhibitor | 200 | 274 | IPR032675 | - | |
Phac4g01635 | 1008 | Gene3D | Ribonuclease Inhibitor | 36 | 199 | IPR032675 | - | |
Phac4g01635 | 1008 | FunFam | LRR receptor-like serine/threonine-protein kinase ERL1 | 201 | 310 | - | - | |
Phac4g01635 | 1008 | ProSitePatterns | Protein kinases ATP-binding region signature. | 666 | 688 | IPR017441 | GO:0005524 | |
Phac4g01635 | 1008 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 736 | 955 | - | - | |
Phac4g01635 | 1008 | Gene3D | Phosphorylase Kinase; domain 1 | 629 | 735 | - | - | |
Phac4g01635 | 1008 | ProSiteProfiles | Leucine-rich repeat profile. | 178 | 200 | IPR001611 | GO:0005515 | |
Phac4g01635 | 1008 | ProSiteProfiles | Protein kinase domain profile. | 660 | 949 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac4g01635 | 1008 | SUPERFAMILY | L domain-like | 36 | 320 | - | - | |
Phac4g01635 | 1008 | SUPERFAMILY | L domain-like | 317 | 574 | - | - | |
Phac4g01635 | 1008 | SUPERFAMILY | Protein kinase-like (PK-like) | 639 | 945 | IPR011009 | - | |
Phac4g01635 | 1008 | Gene3D | Transferase(Phosphotransferase) domain 1 | 736 | 953 | - | - | |
Phac4g01635 | 1008 | Gene3D | Ribonuclease Inhibitor | 275 | 584 | IPR032675 | - | |
Phac4g01635 | 1008 | FunFam | LRR receptor-like serine/threonine-protein kinase ERL1 | 311 | 584 | - | - | |
Phac4g01635 | 1008 | FunFam | LRR receptor-like serine/threonine-protein kinase ERL1 | 36 | 200 | - | - | |
Phac4g01635 | 1008 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 781 | 793 | IPR008271 | GO:0004672|GO:0006468 | |
Phac4g01635 | 1008 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 631 | 735 | - | - | |
Phac4g01635 | 1008 | Pfam | Protein kinase domain | 663 | 942 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac4g01635 | 1008 | PANTHER | LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED | 174 | 947 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Phac4g01635 | Phac-Chr4 | 43651145 | 43659272 | Dispersed/Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Phac4g01635 | 272 | 554 | Receptor kinase-like Gene Family | AT5G07180 | 36.482 | 1.49e-45 | 175 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XIIIb | Phac4g01635 | Pkinase | 3.1e-46 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Phac4g01635 | K20718 | - | gmx:100305433 | 1761.89 |